Skip to main content
. 2022 May 6;17(5):e0266472. doi: 10.1371/journal.pone.0266472

Fig 6. Working model for AICAR-mediated regulation of hepatic Fet-A expression.

Fig 6

Metformin or AICAR increases the phosphorylation of AMPK, which activates p38 MAPK. As a result, AMPK-p38MAPK signaling suppresses high-glucose induced Fet-A expression either by increasing proteasomal degradation and/or by decreasing hepatic expression of C/EBP beta.